To determine whether TMEM106A knockdown induces HCC EMT by activating the Erk1/2/Slug signaling pathway, HepG2-shTMEM106A cells were treated with an Erkl/2 inhibitor, FR 180204. Here, MAPK3 is linked to hepatocellular carcinoma.